Loading…

Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs

The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 1991-02, Vol.5 Suppl 1 (1), p.45-56
Main Authors: Cevese, A, Schena, F, Cerutti, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3
cites cdi_FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3
container_end_page 56
container_issue 1
container_start_page 45
container_title Cardiovascular drugs and therapy
container_volume 5 Suppl 1
creator Cevese, A
Schena, F
Cerutti, G
description The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC was administered in bolus (20, 60, and 200 mg/kg) or by infusion (20 mg/kg/min * 15 min or 30 mg/kg/min * 10 min). In some cases also L-carnitine (LC) and L-carnitine+propionate (LC + P) were administered in doses equimolar to those of PLC. PLC elicited dose-dependent, short-lasting enhancements of cardiac output, both in open- and closed-chest conditions. Arterial blood pressure, heart rate, and contractility varied slightly and unpredictably; the substance did not elicit electrocardiographic effects. These responses were not changed by alpha- or beta-adrenergic blockade, nor by the administration of a calcium antagonist, but they were abolished or reversed by the combination of such blocking interventions. Mesenteric and iliac blood flows were increased by both PLC and LC; LC + P increased these, and in addition increased renal blood flow. A strong diuresis obtained with PLC, LC, and LC + P was due to osmotic clearance following the administration of hyperosmotic solutions. PLC elicited coronary vasodilation with reduced oxygen extraction; this effect lasted longer than the general hemodynamic effects and was not seen with LC. All the cardiovascular actions of PLC can be attributed to its pharmacologic properties, rather than to its role as a metabolic intermediate.
doi_str_mv 10.1007/BF00128243
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80566205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80566205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3</originalsourceid><addsrcrecordid>eNpFkMFLwzAchYMoc04v3oWePAjVX5I2aY46nAoDDyp4K2mTuEibzCQT5l9vxKGnd_ne4-MhdIrhEgPwq5sFACYNqegemuKa05KTCu-jKQgCJSXADtFRjO-QYSGaCZoQoLjheIpen1Y-pDLpMBYrPXq1dXK0faGN0X2KhTeFdSnIT-38Jhbr4NfWu-1QLsteBmeTdToThXQ6ppVO9kurQvm3eIwOjByiPtnlDL0sbp_n9-Xy8e5hfp3rWTiVVBGuKOmhAkMkVJLyCjOuTFVL2VAmIHsyXhvRi85IMDw3mO6wwZIJ1tEZOv_dzWofmyzRjjb2ehiyUTZuG6gZI1Bn8OIX7IOPMWjTroMdZdi2GNqfG9v_GzN8tlvddKNWf-juN_oNCgFtMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80566205</pqid></control><display><type>article</type><title>Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs</title><source>Springer LINK Archives</source><creator>Cevese, A ; Schena, F ; Cerutti, G</creator><creatorcontrib>Cevese, A ; Schena, F ; Cerutti, G</creatorcontrib><description>The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC was administered in bolus (20, 60, and 200 mg/kg) or by infusion (20 mg/kg/min * 15 min or 30 mg/kg/min * 10 min). In some cases also L-carnitine (LC) and L-carnitine+propionate (LC + P) were administered in doses equimolar to those of PLC. PLC elicited dose-dependent, short-lasting enhancements of cardiac output, both in open- and closed-chest conditions. Arterial blood pressure, heart rate, and contractility varied slightly and unpredictably; the substance did not elicit electrocardiographic effects. These responses were not changed by alpha- or beta-adrenergic blockade, nor by the administration of a calcium antagonist, but they were abolished or reversed by the combination of such blocking interventions. Mesenteric and iliac blood flows were increased by both PLC and LC; LC + P increased these, and in addition increased renal blood flow. A strong diuresis obtained with PLC, LC, and LC + P was due to osmotic clearance following the administration of hyperosmotic solutions. PLC elicited coronary vasodilation with reduced oxygen extraction; this effect lasted longer than the general hemodynamic effects and was not seen with LC. All the cardiovascular actions of PLC can be attributed to its pharmacologic properties, rather than to its role as a metabolic intermediate.</description><identifier>ISSN: 0920-3206</identifier><identifier>EISSN: 1573-7241</identifier><identifier>DOI: 10.1007/BF00128243</identifier><identifier>PMID: 2031871</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Carnitine - analogs &amp; derivatives ; Carnitine - pharmacology ; Coronary Circulation - drug effects ; Dogs ; Female ; Hemodynamics - drug effects ; Infusions, Intravenous ; Injections, Intravenous ; Kidney - drug effects ; Male</subject><ispartof>Cardiovascular drugs and therapy, 1991-02, Vol.5 Suppl 1 (1), p.45-56</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3</citedby><cites>FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2031871$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cevese, A</creatorcontrib><creatorcontrib>Schena, F</creatorcontrib><creatorcontrib>Cerutti, G</creatorcontrib><title>Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs</title><title>Cardiovascular drugs and therapy</title><addtitle>Cardiovasc Drugs Ther</addtitle><description>The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC was administered in bolus (20, 60, and 200 mg/kg) or by infusion (20 mg/kg/min * 15 min or 30 mg/kg/min * 10 min). In some cases also L-carnitine (LC) and L-carnitine+propionate (LC + P) were administered in doses equimolar to those of PLC. PLC elicited dose-dependent, short-lasting enhancements of cardiac output, both in open- and closed-chest conditions. Arterial blood pressure, heart rate, and contractility varied slightly and unpredictably; the substance did not elicit electrocardiographic effects. These responses were not changed by alpha- or beta-adrenergic blockade, nor by the administration of a calcium antagonist, but they were abolished or reversed by the combination of such blocking interventions. Mesenteric and iliac blood flows were increased by both PLC and LC; LC + P increased these, and in addition increased renal blood flow. A strong diuresis obtained with PLC, LC, and LC + P was due to osmotic clearance following the administration of hyperosmotic solutions. PLC elicited coronary vasodilation with reduced oxygen extraction; this effect lasted longer than the general hemodynamic effects and was not seen with LC. All the cardiovascular actions of PLC can be attributed to its pharmacologic properties, rather than to its role as a metabolic intermediate.</description><subject>Animals</subject><subject>Carnitine - analogs &amp; derivatives</subject><subject>Carnitine - pharmacology</subject><subject>Coronary Circulation - drug effects</subject><subject>Dogs</subject><subject>Female</subject><subject>Hemodynamics - drug effects</subject><subject>Infusions, Intravenous</subject><subject>Injections, Intravenous</subject><subject>Kidney - drug effects</subject><subject>Male</subject><issn>0920-3206</issn><issn>1573-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpFkMFLwzAchYMoc04v3oWePAjVX5I2aY46nAoDDyp4K2mTuEibzCQT5l9vxKGnd_ne4-MhdIrhEgPwq5sFACYNqegemuKa05KTCu-jKQgCJSXADtFRjO-QYSGaCZoQoLjheIpen1Y-pDLpMBYrPXq1dXK0faGN0X2KhTeFdSnIT-38Jhbr4NfWu-1QLsteBmeTdToThXQ6ppVO9kurQvm3eIwOjByiPtnlDL0sbp_n9-Xy8e5hfp3rWTiVVBGuKOmhAkMkVJLyCjOuTFVL2VAmIHsyXhvRi85IMDw3mO6wwZIJ1tEZOv_dzWofmyzRjjb2ehiyUTZuG6gZI1Bn8OIX7IOPMWjTroMdZdi2GNqfG9v_GzN8tlvddKNWf-juN_oNCgFtMw</recordid><startdate>199102</startdate><enddate>199102</enddate><creator>Cevese, A</creator><creator>Schena, F</creator><creator>Cerutti, G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199102</creationdate><title>Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs</title><author>Cevese, A ; Schena, F ; Cerutti, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Animals</topic><topic>Carnitine - analogs &amp; derivatives</topic><topic>Carnitine - pharmacology</topic><topic>Coronary Circulation - drug effects</topic><topic>Dogs</topic><topic>Female</topic><topic>Hemodynamics - drug effects</topic><topic>Infusions, Intravenous</topic><topic>Injections, Intravenous</topic><topic>Kidney - drug effects</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cevese, A</creatorcontrib><creatorcontrib>Schena, F</creatorcontrib><creatorcontrib>Cerutti, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular drugs and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cevese, A</au><au>Schena, F</au><au>Cerutti, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs</atitle><jtitle>Cardiovascular drugs and therapy</jtitle><addtitle>Cardiovasc Drugs Ther</addtitle><date>1991-02</date><risdate>1991</risdate><volume>5 Suppl 1</volume><issue>1</issue><spage>45</spage><epage>56</epage><pages>45-56</pages><issn>0920-3206</issn><eissn>1573-7241</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>The effects of intravenous administration of propionyl-L-carnitine (PLC) were investigated in anesthetized dogs instrumented for the analysis of general hemodynamic and electrocardiographic data, peripheral blood flows, coronary blood flow and oxygen consumption, urine flow, and renal function. PLC was administered in bolus (20, 60, and 200 mg/kg) or by infusion (20 mg/kg/min * 15 min or 30 mg/kg/min * 10 min). In some cases also L-carnitine (LC) and L-carnitine+propionate (LC + P) were administered in doses equimolar to those of PLC. PLC elicited dose-dependent, short-lasting enhancements of cardiac output, both in open- and closed-chest conditions. Arterial blood pressure, heart rate, and contractility varied slightly and unpredictably; the substance did not elicit electrocardiographic effects. These responses were not changed by alpha- or beta-adrenergic blockade, nor by the administration of a calcium antagonist, but they were abolished or reversed by the combination of such blocking interventions. Mesenteric and iliac blood flows were increased by both PLC and LC; LC + P increased these, and in addition increased renal blood flow. A strong diuresis obtained with PLC, LC, and LC + P was due to osmotic clearance following the administration of hyperosmotic solutions. PLC elicited coronary vasodilation with reduced oxygen extraction; this effect lasted longer than the general hemodynamic effects and was not seen with LC. All the cardiovascular actions of PLC can be attributed to its pharmacologic properties, rather than to its role as a metabolic intermediate.</abstract><cop>United States</cop><pmid>2031871</pmid><doi>10.1007/BF00128243</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-3206
ispartof Cardiovascular drugs and therapy, 1991-02, Vol.5 Suppl 1 (1), p.45-56
issn 0920-3206
1573-7241
language eng
recordid cdi_proquest_miscellaneous_80566205
source Springer LINK Archives
subjects Animals
Carnitine - analogs & derivatives
Carnitine - pharmacology
Coronary Circulation - drug effects
Dogs
Female
Hemodynamics - drug effects
Infusions, Intravenous
Injections, Intravenous
Kidney - drug effects
Male
title Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T12%3A39%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short-term%20hemodynamic%20effects%20of%20intravenous%20propionyl-L-carnitine%20in%20anesthetized%20dogs&rft.jtitle=Cardiovascular%20drugs%20and%20therapy&rft.au=Cevese,%20A&rft.date=1991-02&rft.volume=5%20Suppl%201&rft.issue=1&rft.spage=45&rft.epage=56&rft.pages=45-56&rft.issn=0920-3206&rft.eissn=1573-7241&rft_id=info:doi/10.1007/BF00128243&rft_dat=%3Cproquest_cross%3E80566205%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282t-3d27d32c040f2a04a374167df45aa83690187675f9c9bfa0f73d26eb1f1a696b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80566205&rft_id=info:pmid/2031871&rfr_iscdi=true